Archives
Environmental Benefit Seen With GLP-1 Receptor Agonist Use in Heart Failure
Heart failure event-related greenhouse gas emissions estimated at 9.45 and 9.70 kg CO2e per patient per year for GLP-1 RA and placebo users, respectively
Older Age, Lower Fitness Linked to Atrial Ectopic Burden
Older age was also an independent risk factor for ventricular ectopic burden; lower eGFR linked to high AEB, VEB
Diabetes Risk Commonly Clustered Within Households
Health systems can use electronic health record data to target households rather than just individuals, authors say
Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors
Overall, 68.9 percent of participants who underwent screening at health stations had uncontrolled cardiovascular risk factors
Three Healthy Dietary Patterns Lower Incidence of Type 2 Diabetes Across Ethnicities
No significant heterogeneity seen across ethnic groups, nor evidence of small-study bias
Lifestyle Interventions Improve Cognition for At-Risk Older Adults
Significantly greater benefit on global cognition seen for structured versus self-guided intervention over two years
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester
ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy
The EfficientNetB0 achieved more than 99 percent accuracy, with image processing speed <1 second per image
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio
ENDO: Osteoporosis Treatment Benefits Elderly Patients With Fragility Fracture
Benefits include lower incidence of all-cause mortality, hospitalizations